ROR score aids prognosis after 5 years on tamoxifen

The risk of recurrence (ROR) score provides clinically meaningful prognostic information after postmenopausal women with early-stage breast cancer complete 5 years of tamoxifen therapy, according to...

Field of Interest: Pulmonology
Type: News Item

Androgen-deprivation therapy linked to cardiac death

Androgen-deprivation therapy for prostate cancer may increase the risk of cardiac death among men who have congestive heart failure or who have experienced a previous myocardial infarction, a...

Field of Interest: Oncology
Type: News Item

Should ductal carcinoma in situ be treated?

Remarks given during a session of the ASCO Breast Cancer Symposium titled Ductal Carcinoma in Situ Debate: Treatment vs. Observation Dr. Kuerer comments: There has been a marked...

Field of Interest: Oncology
Type: News Item

Should ductal carcinoma in situ be treated?

Remarks given during a session of the ASCO Breast Cancer Symposium titled Ductal Carcinoma in Situ Debate: Treatment vs. Observation Dr. Kuerer comments: There has been a marked...

Field of Interest: Pulmonology
Type: News Item

Adnexal masses in pregnancy

With the increasing use of ultrasound in the first trimester, asymptomatic adnexal masses are being diagnosed earlier in pregnancy, leaving providers with an often difficult clinical scenario. The...

Field of Interest: Oncology
Type: News Item

Adnexal masses in pregnancy

With the increasing use of ultrasound in the first trimester, asymptomatic adnexal masses are being diagnosed earlier in pregnancy, leaving providers with an often difficult clinical scenario. The...

Field of Interest: Pulmonology
Type: News Item

20-year follow-up supports adjuvant radiotherapy for DCIS

Adjuvant radiotherapy continues to protect against recurrences – ­albeit “modestly” – for a full 20 years after women undergo breast-conserving surgery for DCIS, according to a report published...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.